Behavioural and the EEG response to various centrally active drugs has been suggested frequently as a way to distin guish schizophrenic populations (6, 9) . In following this model, intravenous thio pental 'has found increased use both in diagnosis and in prognosis (4, 14) . In a series of detailed studies, schizophrenic patients presenting an organic mental syndrome have exhibited a special sensi tivity to thiopental. Clinically they de veloped a deep narcosis and their EEGs showed enhanced delta activity (7) .
The aim of this study was to assess the value of a psychotomimetic com pound such as phencyclidinet for use in the diagnosis and prognosis of schizo phrenic patients. Because phencyclidine displays a dual effect in the central ner vous system, which is demonstrated by blocking sensory perception and pro ducing hallucinogenic activity (5, 11), it was selected for these investigations. Psychotomimetic activity is apparent following the administration of low dosages. In high dosages the anesthetic effect with changes in consciousness pre dominates. •
Material and Methods
This report includes 29 investigations (fixed dosage of 0.05 mg/kg in 5-minute i.v. administration) in ten bilateral pre frontal standard lobotomized (organic) and in 19 non-lobotomized (non-organic) schizophrenics who had not received any psychotropic drugs for a minimum period of eight weeks. Prior to and 30 minutes after injection, brief neurological examinations and psychiatric interviews were done, using special rating scales (MlP-Itil, et. al.) . Population character istics of this group of patients have been tabulated in Table I. During each investigation, EMG, EKG and eye movements were registered simultaneously with the EEG recording for periods up to one hour following the administration of the drug. EEG recordings of the right occipital to ear lead were analyzed using an electronic frequency analyzer (power spectrum analysis). The difference in frequency spectra before and after the drug was called the individual 'phencyclidine res ponse'. The group response was deter mined by averaging individual responses.
Results

Psy chopathological changes
An increase or a decrease of existing psychotic symptoms, as well as the oc currence of new symptomatology, was observed in varying degrees after phen cyclidine in both lobotomized and nonlobotomized groups. However, the de gree of alteration in the symptoms was much less in the lobotomized patients than in the non-lobotomized. The changes per sisted for 15 minutes to two hours and the maximum effect was observed from 20-45 minutes. An increase in the indivi dual symptom scores ranged from 10-90%, while a decrease in some symptom scores ranged from 10-40% in all sub jects.
The statistical analysis showed signifi cant differences between the lobotomized and non-lobotomized groups regarding the occurrence of fluctuation of con sciousness, visual hallucinations and overtalkativeness (Table II) . 
EEG Changes
Characteristic changes which 'have been described in earlier reports (2, 13) were also observed in our investigations. A comparison of the pre-and post-drug frequency spectra averages (phencycli dine response) showed quantitative dif ferences in the EEG response between the two groups of schizophrenics. There was a marked response (a greater de crease in alpha activity) in the nonlobotomized group than in the loboto mized patients (Fig. 1) .
Conclusions
There were significant clinical and EEG differences in response to phen cyclidine between lobotomized (or ganic) and non-lobotomized (non-or ganic) schizophrenic groups. The in- ability of lobotomized patients to exhibit marked phencyclidine effects in compari son to those seen in non-lobotomized subjects suggests that the thalamocortical integrative mechanism may be necessary to produce typical phencyclidine res ponse. It is known that the interruption of the thalamofrontal radiation by lobotomy impairs the thalamocortical integ rative function (10) which may be due to retrograde degeneration of the thala mus (3). Our clinical and EEG results suggest that it is possible phencyclidine acts on the thalamocortical system, as has already been reported (1, 12) . In our unpublished investigations on therapy resistant and responsive schizo phrenics, the response to phencyclidine in resistant patients showed some simi larity to that found in lobotomized pa tients. This seems to suggest that both groups may 'have common underlying functional deficiencies. Thus, resistance to drug treatment in some patients might be linked to impaired thalamocortical integrative functions due to the disease process or exogenous factors. Our thio pental EEG investigations and therapeu tic trials with these various groups of patients also substantiate this hypothesis (8).
